Quarterly Report • Nov 18, 2025
Quarterly Report
Open in ViewerOpens in native device viewer

This document is a partial unofficial translation for convenience only of the Hebrew original of the financial report of Meitav Investment House Ltd. as of September 30, 2025, that was submitted to the Tel-Aviv Stock Exchange and the Israeli Securities Authority on November 18, 2025. The Hebrew version submitted to the TASE and the Israeli Securities Authority shall be the sole legally binding version. For the details of the policy, see the Company's immediate report dated August 19, 2024 (reference number: 2024-01-08-4447)
| Page | |
|---|---|
| Consolidated Statements of Financial Position | 2 - 3 |
| Consolidated Statements of Profit or Loss and Other Comprehensive Income | 4 |
| Consolidated Statements of Changes in Equity | 5 - 9 |
| Consolidated Statements of Cash Flows | 10 - 12 |
| September 30, |
||||
|---|---|---|---|---|
| 2025 | 2024 | December 31, 2024 |
||
| Unaudited | ||||
| NIS in millions | ||||
| ASSETS | ||||
| CURRENT ASSETS: | ||||
| Cash and cash equivalents | 194 | 262 | 205 | |
| Short-term investments | 377 | 313 | 324 | |
| Customer credit | 2,273 | 1,738 | 1,977 | |
| Trade receivables | 105 | 106 | 105 | |
| Other accounts receivable | 193 | 105 | 130 | |
| Current taxes receivable | 10 | 17 | 8 | |
| 3,152 | 2,541 | 2,749 | ||
| NON-CURRENT ASSETS: | ||||
| Investments of provident fund members | 109 | 103 | 103 | |
| Investments, loans and receivables | 1,236 | 984 | 1,002 | |
| Investments in associates | 22 | 24 | 22 | |
| Fixed assets | 167 | 165 | 172 | |
| Deferred taxes | 54 | 67 | 79 | |
| Intangible assets | 1,440 | 1,305 | 1,350 | |
| 3,028 | 2,648 | 2,728 | ||
| 6,180 | 5,189 | 5,477 |
| September | 30, | December 31, | |
|---|---|---|---|
| 2025 | 2024 | 2024 | |
| Unaudited | Audited | ||
| NIS in millions | |||
| LIABILITIES AND EQUITY | |||
| CURRENT LIABILITIES: | |||
| Credit from banks and other credit providers | 2,161 | 1,642 | 1,910 |
| Liabilities for short sale of securities | 116 | 42 | 91 |
| Trade payables | 158 | 114 | 134 |
| Other accounts payable | 321 | 281 | 251 |
| Provisions for legal claims | 143 | 670 | 676 |
| Current taxes payable | 50 | 48 | 54 |
| 2,949 | 2,797 | 3,116 | |
| NON-CURRENT LIABILITIES: | |||
| Debentures | 679 | 611 | 477 |
| Credit from banks and other credit providers | 662 | 437 | 484 |
| Liabilities to provident fund members | 113 | 110 | 109 |
| Lease liabilities | 127 | 130 | 134 |
| Employee benefit liabilities | 6 | 6 | 6 |
| Deferred taxes | 35 | 34 | 34 |
| 1,622 | 1,328 | 1,244 | |
| Total liabilities | 4,571 | 4,125 | 4,360 |
| EQUITY: | |||
| Share capital | 77 | 77 | 77 |
| Share premium | 620 | 635 | 635 |
| Capital reserve for share-based payment transactions | 55 | 47 | 48 |
| Retained earnings | 819 | 176 | 222 |
| Other reserves | (144) | (132) | (134) |
| Equity attributable to equity holders of the Company | 1,427 | 803 | 848 |
| Non-controlling interests | 182 | 261 | 269 |
| Total equity | 1,609 | 1,064 | 1,117 |
| 6,180 | 5,189 | 5,477 | |
| Novembe18, 2025 | |||
| Date of approval of the Zvi Stepak |
Ilan Raviv | Einat Rom | |
| financial statements Chairman of the Board |
CEO | CFO |
| Nine months ended September 30, 2025 2024 |
Three months ended September 30, 2025 2024 |
Year ended December 31, |
|||
|---|---|---|---|---|---|
| Unaudited | 2024 Audited |
||||
| NIS in millions (except per share data) | |||||
| Revenue from management fees, | |||||
| commissions and other, net | 1,155 | 945 | 416 | 332 | 1,301 |
| Income from non-bank loans activity | 288 | 233 | 99 | 81 | 318 |
| Total revenues | 1,443 | 1,178 | 515 | 413 | 1,619 |
| Income refund in respect of legal claims | 203 | - | 203 | - | (2) |
| Total revenues | 1,646 | 1,178 | 718 | 413 | 1,617 |
| Marketing, operating, general and administrative | |||||
| expenses | 832 | 733 | 288 | 249 | 1,004 |
| Finance expenses on non-bank loans | 119 | 96 | 43 | 36 | 134 |
| Operating income | 695 | 349 | 387 | 128 | 479 |
| Gain from securities held for investment purposes in | |||||
| nostro portfolio, net Finance income |
17 25 |
7 18 |
6 2 |
2 6 |
12 20 |
| Finance expenses | (51) | (46) | (13) | (16) | (53) |
| Finance income (expenses) in respect of legal claims | 217 | (28) | 236 | (12) | (32) |
| Other expenses, net | (7) | (3) | (3) | (3) | (6) |
| Company's share of income (losses) of companies | |||||
| accounted for at equity, net | 1 | (27) | 1 | (2) | (27) |
| Income before taxes on income | 897 | 270 | 616 | 103 | 393 |
| Taxes on income | 136 | 76 | 64 | 32 | 103 |
| Net income for the period | 761 | 194 | 552 | 71 | 290 |
| Other comprehensive income (loss) (net of tax effect): | |||||
| Foreign currency translation adjustments of foreign | |||||
| operations | 1 | 1 | - | - | (1) |
| Total other comprehensive income | 1 | 1 | - | - | (1) |
| Total comprehensive income | 762 | 195 | 552 | 71 | 289 |
| Net income attributable to: | |||||
| Equity holders of the Company Non-controlling interests |
727 34 |
170 24 |
542 10 |
62 9 |
256 34 |
| 761 | 194 | 552 | 71 | 290 | |
| Comprehensive income attributable to: | |||||
| Equity holders of the Company | 728 | 171 | 542 | 62 | 255 |
| Non-controlling interests | 34 | 24 | 10 | 9 | 34 |
| 762 | 195 | 552 | 71 | 289 | |
| Basic and diluted net earnings per share attributable to | |||||
| equity holders of the Company (in NIS): | |||||
| Basic net earnings | 9.25 | 2.17 | 6.88 | 0.79 | 3.26 |
| Diluted net earnings | 9.24 | 2.17 | 6.87 | 0.79 | 3.26 |
| Share capital |
Share premium |
Capital reserve from share-based payment transactions | Retained earnings | Other reserves | Total | Non- controlling interests |
Total equity |
|
|---|---|---|---|---|---|---|---|---|
| Unaudi NIS in mi |
||||||||
| - | N15 III IIII | IIIOIIS | ||||||
| Balance at January 1, 2025 (audited) | 77 | 635 | 48 | 222 | (134) | 848 | 269 | 1,117 |
| Net income for the period | _ | _ | - | 727 | _ | 727 | 34 | 761 |
| Other comprehensive income, net | - | 1 | 1 | 1 | ||||
| Total comprehensive income | _ | _ | _ | 727 | 1 | 728 | 34 | 762 |
| Dividend declared and paid | - | _ | - | (130) | - | (130) | - | (130) |
| Dividend to non-controlling interests | - | - | - | - | - | - | (25) | (25) |
| Net purchases of non-controlling interests | - | - | - | - | (9) | (9) | (111) | (120) |
| Exercise of options in a subsidiary | - | - | _ | - | (2) | (2) | 10 | 8 |
| Share-based payment | - | - | 7 | - | - | 7 | 5 | 12 |
| Repurchase of the company's shares | (15) | (15) | (15) | |||||
| Balance at September 30, 2025 | 77 | 620 | 55 | 819 | (144) | 1,427 | 182 | 1,609 |
| Attribut | able to equity ho | olders of the C | ompany | |||||
|---|---|---|---|---|---|---|---|---|
| Capital reserve from share-based | Non- | |||||||
| Share capital |
Share premium |
payment transactions |
Retained earnings | Other reserves | Total | controlling interests | Total equity |
|
| Unaudi | ||||||||
| NIS in mi | llions | |||||||
| Balance at January 1, 2024 (audited) | 77 | 635 | 42 | 85 | (117) | 722 | 229 | 951 |
| Net income for the period | - | - | - | 170 | - | 170 | 24 | 194 |
| Other comprehensive income, net | - | 1 | 1 | 11 | ||||
| Total comprehensive income | _ | _ | - | 170 | 1 | 171 | 24 | 195 |
| Dividend declared and paid | - | - | - | (79) | - | (79) | - | (79) |
| Dividend to non-controlling interests | - | - | - | - | - | - | (15) | (15) |
| Issue of capital and options to non-controlling | 1.5 | 1.5 | 2.4 | 40 | ||||
| interests (net of issuance expenses) | - | - | - | - | 15 | 15 | 34 | 49 |
| Share-based payment | - | - | 5 | - | - | 5 | 3 | 8 |
| Derecognition of non-controlling interests due to | (1) | (1) | ||||||
| sale of subsidiary Transaction with non-controlling interest in an | - | - | - | - | - | - | (1) | (1) |
| associate | (33) | (33) | (33) | |||||
| Net purchases of non-controlling interests | - | - | - | - | (33) | (33) | (13) | (11) |
| The parenases of hon controlling interests | · | (13) | (11) | |||||
| Balance at September 30, 2024 | 77 | 635 | 47 | 176 | (132) | 803 | 261 | 1,064 |
| Attributable to equity holders of the Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Capital reserve from share-based payment transactions | Retained earnings |
Other reserves | Total | Non- controlling interests |
Total equity |
|
| Unaudi | ||||||||
| NIS in mi | illions | |||||||
| Balance at July 1, 2025 | 77 | 620 | 52 | 322 | (144) | 927 | 177 | 1,104 |
| Net income for the period Other comprehensive income, net |
- - |
542 | - | 542 | 10 | 552 | ||
| Total comprehensive income Dividend declared and paid Dividend to non-controlling interests Share-based payment |
- - - - |
- - - - |
- - - 3 |
542 (45) |
- - - - |
542 (45) |
10 (7) 2 |
552 (45) (7) 5 |
| Balance at September 30, 2025 | 77 | 620 | 55 | 819 | (144) | 1,427 | 182 | 1,609 |
| Attributable to equity holders of the Company | ||||||||
|---|---|---|---|---|---|---|---|---|
| Share capital |
Share premium |
Capital reserve from share-based payment transactions | Retained earnings |
Other reserves | Total | Non- controlling interests |
Total equity |
|
| Unaudi | ||||||||
| - | NIS in mi | llions | ||||||
| Balance at July 1, 2024 | 77 | 635 | 46 | 133 | (103) | 788 | 268 | 1,056 |
| Net income for the period | _ | _ | _ | 62 | _ | 62 | 9 | 71 |
| Other comprehensive income, net | - | . | - | |||||
| Total comprehensive income | _ | _ | _ | 62 | _ | 62 | 9 | 71 |
| Dividend declared and paid | _ | _ | _ | (19) | - | (19) | - | (19) |
| Dividend to non-controlling interests | - | - | - | - | - | (4) | (4) 2 |
|
| Share-based payment | - | - | 1 | - | - | 1 | 1 | 2 |
| Transaction with non-controlling interest in an | (22) | (22) | (22) | |||||
| associate Net purchases of non-controlling interests | - | - | - | - | (33) | (33) | (12) | (33) |
| Net purchases of non-controlling interests | 4 | (13) | (9) | |||||
| Balance at September 30, 2024 | 77 | 635 | 47 | 176 | (132) | 803 | 261 | 1,064 |
| Attribut | ||||||||
|---|---|---|---|---|---|---|---|---|
| Capital reserve from share-based | Non- | |||||||
| Share capital | Share premium | payment transactions |
Accumulated earnings | Other reserves | Total | controlling interests |
Total equity | |
| Audite | ||||||||
| NIS in mil | lions | |||||||
| Balance at January 1, 2024 | 77 | 635 | 42 | 85 | (117) | 722 | 229 | 951 |
| Net income for the year | _ | _ | _ | 256 | _ | 256 | 34 | 290 |
| Other comprehensive income, net | (1) | (1) | (1) | |||||
| Total comprehensive income | _ | _ | _ | 256 | (1) | 255 | 34 | 289 |
| Dividend declared and paid | - | _ | - | (119) | - | (119) | - | (119) |
| Dividend to non-controlling interests | - | - | - | ` - | - | - | (21) | (21) |
| Issue of capital and options to non-controlling | ||||||||
| interests (net of issuance expenses) | - | - | - | - | 15 | 15 | 34 | 49 |
| Share-based payment | - | - | 6 | - | - | 6 | 7 | 13 |
| Net purchases of non-controlling interests | - | - | - | - | 2 | 2 | (13) | (11) |
| Transaction with non-controlling interest in an | (22) | (2.2) | (22) | |||||
| associate | - | - | - | - | (33) | (33) | - | (33) |
| Derecognition of non-controlling interests due to sale of subsidiary | (1) | (1) | ||||||
| Balance at December 31, 2024 | 77 | 635 | 48 | 222 | (134) | 848 | 269 | 1,117 |
| Nine months ended September 30, |
Three months ended September |
30, | Year ended December 31, |
||
|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | 2024 | |
| Unaudited | Audited | ||||
| NIS in millions | |||||
| Cash flows from operating activities: | |||||
| Net income for the period | 761 | 194 | 552 | 71 | 290 |
| Adjustments to reconcile net income to net cash provided by operating activities: |
|||||
| Adjustments to the profit or loss items: | |||||
| Depreciation of fixed assets | 26 | 22 | 10 | 7 | 31 |
| Amortization of intangible assets | 49 | 44 | 17 | 15 | 60 |
| Gain from sale of investment in | |||||
| consolidated subsidiary Amortization of deferred acquisition costs |
- 51 |
(3) 33 |
- 20 |
- 12 |
(3) |
| Revaluation of investments to provident | 48 | ||||
| fund members | (6) | (3) | (2) | (1) | (3) |
| Revaluation of liabilities to provident | |||||
| fund members | 4 | 5 | 1 | 1 | 4 |
| Company's share of losses (income) of | |||||
| companies accounted for at equity, net | (1) | 27 | (1) | 2 | 27 |
| Deferred taxes, net | 26 | (20) | 25 | (6) | (32) |
| Revaluation of debentures | 6 | 9 | 4 | 4 | 9 |
| Gains from securities measured at fair | |||||
| value through profit or loss, net | (29) | (25) | (7) | (5) | (39) |
| Change in short-term deposits | 1 | (6) | - | (1) | - |
| Share-based payment | 12 | 8 | 5 | 2 | 13 |
| 139 | 91 | 72 | 30 | 115 | |
| Changes in asset and liability items: Customer credit, trade receivables and |
|||||
| other accounts receivable | (596) | (625) | (173) | (112) | (899) |
| Short-term credit from giving non-bank loans |
34 | 382 | (61) | 24 | 594 |
| Trade payables, provisions for legal claims and other accounts payable |
(589) | (14) | (657) | 39 | (75) |
| (1,151) | (257) | (891) | (49) | (380) | |
| Net cash provided by (used to) operating activities |
(251) | 28 | (267) | 52 | 25 |
| Nine months ended September 30, |
Three months ended September 30, |
Year ended December 31, |
|||
|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | 2024 | |
| Unaudited | Audited | ||||
| NIS in millions | |||||
| Cash flows from investing activities: | |||||
| Sale (purchase) of short-term investments measured at fair value through profit or loss |
(26) | (13) | (92) | (8) | 13 |
| Purchase of fixed assets | (6) | (9) | (2) | (1) | (12) |
| Purchase of intangible assets | (41) | (43) | (16) | (14) | (59) |
| Repayment of restricted deposit | - | 352 | - | 352 | 352 |
| Change in restricted deposits, net | 8 | 31 | (2) | (11) | 23 |
| Investment in companies accounted for at | |||||
| equity | (8) | (3) | - | - | - |
| Repayment of long-term loan | 9 | - | 1 | - | 6 |
| Sale of investments in subsidiaries (b) | - | 1 | - | - | 1 |
| Net cash provided by (used in) investing activities |
(64) | 316 | (111) | 318 | 324 |
| Cash flows from financing activities: | |||||
| Issuance of commercial securities (net of issuance costs) Issue of subsidiary's debentures (net of |
150 | - | 150 | - | - |
| issuance costs) | 199 | - | - | - | - |
| Repayment of Company debentures | - | - | - | - | (135) |
| Receipt of long-term loans from banks | 174 | 138 | 89 | 13 | 173 |
| Repayment of subsidiary's debentures | - | (148) | - | - | (148) |
| Issuance of capital and options to non |
|||||
| controlling interests | - | 49 | - | - | 49 |
| Dividend paid to the shareholders of the | |||||
| Company | (130) | (79) | (45) | (19) | (119) |
| Dividend paid to non-controlling interests | (25) | (15) | (7) | (4) | (21) |
| Exercise of options in a subsidiary | 8 | - | - | - | - |
| Repayment of long-term lease liabilities | (23) | (18) | (7) | (7) | (25) |
| Purchases of non-controlling interests | (120) | (18) | - | (11) | (18) |
| Repurchase of the Company's shares | (15) | - | - | - | - |
| Repurchase of subsidiary's shares by the | |||||
| subsidiary Proceeds from short purchase of securities, |
- | (1) | - | - | (1) |
| net | 22 | (16) | 38 | - | 10 |
| Loans from other credit providers, net | - | - | (2) | - | 12 |
| Short-term credit from banks, net | 64 | (293) | 1 | (361) | (240) |
| Net cash provided by (used in) financing activities |
304 | (401) | 217 | (389) | (463) |
| Decrease in cash and cash equivalents Cash and cash equivalents at the beginning |
(11) | (57) | (161) | (19) | (114) |
| of the period | 205 | 319 | 355 | 281 | 319 |
| Cash and cash equivalents at the end of the period |
194 | 262 | 194 | 262 | 205 |
| Nine months ended September 30, |
Three months ended September 30, |
Year ended December 31, |
||||
|---|---|---|---|---|---|---|
| 2025 | 2024 | 2025 | 2024 | 2024 | ||
| Unaudited | Audited | |||||
| NIS in millions | ||||||
| (a) | Additional information on cash flows from operating activities: |
|||||
| Cash paid during the period for: | ||||||
| Interest | 65 | 79 | 24 | 23 | 108 | |
| Taxes on income | 93 | 100 | 25 | 23 | 130 | |
| Cash received during the period for: | ||||||
| Interest | 276 | 286 | 127 | 105 | 393 | |
| Taxes on income | 3 | 3 | - | 3 | 11 | |
| (b) | Sale of investments in subsidiaries: | |||||
| Working capital (excluding cash and cash equivalents) |
- | (2) | - | - | (2) | |
| Total assets and liabilities of the subsidiary on date of sale Capital gain from sale of subsidiaries |
- - |
(2) 3 |
- - |
- - |
(2) 3 |
|
| - | 1 | - | - | 1 |

Have a question? We'll get back to you promptly.